Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Neoplasms 2Malnutrition 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Thrombosis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Radiation Injuries 1Protein Metabolism 1Polycystic Ovary Syndrome 1Pain 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Meningioma 1Hemorrhage 1Glioblastoma 1Erectile Dysfunction 1Disease 1Diabetes Insipidus 1Brain Neoplasms 1

Interventions

Vasopressins 3carbetocin 1Tourniquets 1Terlipressin 1Oxytocin 1Misoprostol 1Ethamsylate 1Bupivacaine 1Arginine Vasopressin 1Arginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diabetes Insipidus × Arginine × Clear all
NCT05293041 2025-03-06

ARG-01

Sahlgrenska University Hospital

Phase 4 Completed
248 enrolled

Diabetes Insipidus, Hemorrhage, Pain, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡